HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.

Abstract
Patients with Graves' disease (n = 105) had an increased frequency of HLA-B8 (40%) and a reduced frequency of HLA-B12 (24.8%) when compared with random controls (n = 117; 24.8% and 40.2% respectively). Comparison of patients with their first degree relatives (n = 118) shows the frequency deviations in these antigens to be characteristic of the families from which patients with Graves' disease are drawn, rather than of the disease itself. The haplotypes, identified in eight-six patients and 113 relatives, indicate that the excess of HLA-B8 in patients and their relatives is primarily due to the halpotype 1-8. The relative risk for an HLA-B8 individual of developing Graves' disease is 2.02, whilst the relative risk for an individual of haplotype 1-8 is 4.23. No significant associations were found between the incidence of any HLA antigen or combination thereof and the presence or absence of thyroglobulin and thyroid microsomal antibodies, or antibodies which interact with the TSH receptor.
AuthorsB A Mather, D F Roberts, M F Scanlon, E D Mukhtar, T F Davies, B R Smith, R Hall
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 12 Issue 2 Pg. 155-63 (Feb 1980) ISSN: 0300-0664 [Print] England
PMID6893172 (Publication Type: Journal Article)
Chemical References
  • Autoantibodies
  • HLA Antigens
  • Thyrotropin
  • Thyroglobulin
Topics
  • Autoantibodies (analysis)
  • Graves Disease (genetics, immunology)
  • HLA Antigens (analysis, genetics)
  • Haploidy
  • Humans
  • Microsomes (immunology)
  • Thyroglobulin (immunology)
  • Thyroid Gland (immunology)
  • Thyrotropin (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: